AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

IBUPROFEN + LYSINE

10 registrations across 2 African markets— 8 active

Markets with IBUPROFEN + LYSINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NUROFEN-EXPRESS_684 684MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
NUROFEN-EXPRESS_342 342MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
IBUPROFEN LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN + LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN + LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN + LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive
IBUPROFEN + LYSINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaRECKITT BENCKISER HEALTHCARE (UK) LIMITEDactive

IBUPROFEN + LYSINE in Africa — Regulatory Overview

IBUPROFEN + LYSINE is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.